NFKB1 and Hyperglycemia: As a result, our study showed that 5uM NF-κB inhibitor BAY 11-7082 and high-dose PNS significantly decreased the expression of IκB-alpha phosphorylation, compared with hyperglycemia group (p<0.01) (Figures 4(a) and 4(b)).